Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China (Di venerdì 31 marzo 2023)
SHANGHAI, March 31, 2023 /PRNewswire/
Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted RadioTherapy (TRT) to benefit Cancer patients in China, today announced the Development Plans of a first-in-class novel peptide drug candidate against GPC3. The proprietary GPC3 targeting peptide is being licensed from RayzeBio pursuant to an existing license agreement. Upon in-license of product candidates by Ablaze from RayzeBio, Ablaze will be responsible for clinical Development and commercialization of the product in the Greater China region. The strategic collaboration between Ablaze and ...Leggi su liberoquotidiano
Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted RadioTherapy (TRT) to benefit Cancer patients in China, today announced the Development Plans of a first-in-class novel peptide drug candidate against GPC3. The proprietary GPC3 targeting peptide is being licensed from RayzeBio pursuant to an existing license agreement. Upon in-license of product candidates by Ablaze from RayzeBio, Ablaze will be responsible for clinical Development and commercialization of the product in the Greater China region. The strategic collaboration between Ablaze and ...Leggi su liberoquotidiano
Advertising
Rabia and Rukia face agonising wait to see if doctors can separate their heads Daily Mail
Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver Cancer in Greater China
SHANGHAI, March 31, 2023 /PRNewswire/ -- Ablaze Pharmaceuticals, a biotech company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients in China, today announced the ...Huading Awards Group Announces Red Carpet Guests for the 36th Huading Awards Ceremony
The PONY 500 comes in half the size of competing products in the market and... at 05:00 Ablaze Pharmaceuticals Plans Development of Innovative GPC3 Targeted Radiopharmaceutical Therapy for Liver ...
Ablaze Pharmaceuticals
Segui gli aggiornamenti e vedi gli ultimi video su : Ablaze Pharmaceuticals
Facebook
Tik Tok
Twitter
Instagram
You Tube
